- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5025 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/5025
Total number of patents in this class: 2314
10-year publication summary
|
119
|
145
|
154
|
149
|
202
|
188
|
186
|
218
|
254
|
87
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4848 |
58 |
| Novartis AG | 11041 |
38 |
| F. Hoffmann-La Roche AG | 7889 |
38 |
| Janssen Pharmaceutica N.V. | 3437 |
36 |
| Takeda Pharmaceutical Company Limited | 2702 |
32 |
| Genentech, Inc. | 3888 |
30 |
| Gilead Sciences, Inc. | 2000 |
30 |
| AstraZeneca AB | 2940 |
27 |
| Boehringer Ingelheim International GmbH | 4729 |
26 |
| Nihon Nohyaku Co., Ltd. | 315 |
25 |
| Agios Pharmaceuticals, Inc | 216 |
22 |
| Pfizer Inc. | 3327 |
21 |
| Vanderbilt University | 1834 |
20 |
| Amgen Inc. | 3961 |
19 |
| Hoffmann-La Roche Inc. | 3341 |
18 |
| Merck Sharp & Dohme LLC | 3725 |
18 |
| Bayer Pharma AG | 1058 |
16 |
| Incyte Corporation | 994 |
16 |
| Merck Patent GmbH | 5826 |
15 |
| Prelude Therapeutics, Incorporated | 124 |
15 |
| Other owners | 1794 |